Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Chimeric Therapeutics Ltd. announced the issuance of over 56 million unquoted equity securities, including performance rights and options, as part of an employee incentive scheme. This strategic move could impact the company’s stock dynamics and attract investor interest in the biopharmaceutical sector.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.